top of page
test
Rheumatoid Arthritis Autoantibodies
ANALYTES
Analytes are the substances measured in this test, which include:
Anti-cyclic citrullinated peptide (CCP)
Rheumatoid Factor (RF)
rESULTS
sample Req.
The report evaluates both anti-cyclic citrullinated peptide (CCP) antibodies and rheumatoid factor (RF) along a diagnostic spectrum to assess the likelihood and potential stage of rheumatoid arthritis (RA). Rheumatoid factor, when elevated, may indicate underlying autoimmune activity consistent with Rheumatoid Arthritis, although it can also be present in other inflammatory or autoimmune conditions.
CCP antibodies provide additional specificity, as elevated levels are strongly associated with RA and may be detected even in patients who are RF-negative. Notably, CCP antibodies can be identified in approximately 50 - 60% of individuals within the early stages of RA, often within three to six months of symptom onset.
Interpreting both markers across graded reference ranges allows for assessment of inflammatory activity and supports identification of RA in both established and early-phase presentations.
Blood
cOST
The results of your health assessment have identified specific signs and symptoms that are clinically consistent with an increased risk of
Rheumatoid arthritis
This test investigates ANA or RF markers, which are associated with a range of conditions and signs, which have been clinically verified to include
Chronic joint pain and stiffness
Joint pain particularly in the hands
Loss of joint range of motion
Nail Ridging
Clubbed fingernails
This investigation is optional and may be used to verify the need for autoimmune intervention and immune regulation [ Tregs Dysfunction ].
In the absence of testing for Rheumatoid arthritis, autoimmune management is not included in the treatment plan, unless otherwise indicated. If testing is undertaken, the assessment will be re-evaluated in accordance with the test results. You will be updated with the test results alongside any treatment revisions necessary.
A blood collection kit will be dispatched to you by post.
This collection kit must be presented to an affiliated pathology provider, where a qualified phlebotomist will perform the blood draw and arrange return of the specimen to the laboratory in accordance with standard handling protocols.
Affiliated pathology providers vary by Australian state. Please refer to the list below to identify the appropriate provider for your location:
VIC: Melbourne Pathology
NSW: 4Cyte Pathology
QLD: 4Cyte Pathology
SA: Abbott Pathology
WA: Western Diagnostic Pathology
NT: Western Diagnostic Pathology
TAS: TML Pathology
ACT: 4Cyte Pathology
Estimated Turnaround Time: 5 business days
bottom of page